Cervical Cancer Clinical Trials

University of Alabama at Birmingham
Birmingham Alabama 35294

A clinical trial to evaluate treatments using live-attenuated Listeria monocytogenes cancer vaccine ADXS11-001 and laboratory biomarker analysis for patients with Cervical Cancer

Saint Joseph's Hospital and Medical Center
Phoenix Arizona 85013

A clinical trial to evaluate treatments using live-attenuated Listeria monocytogenes cancer vaccine ADXS11-001 and laboratory biomarker analysis for patients with Cervical Cancer

Georgetown University Hospital
Washington District of Columbia 20007

A clinical research study of Quadrivalent HPV for types 6, 11, 16 and 18 for the treatment of Cervical Cancer, Hpv or Warts

Childrens National Medical Center
Washington District of Columbia 20010

A clinical research study of Quadrivalent HPV for types 6, 11, 16 and 18 for the treatment of Cervical Cancer, Hpv or Warts

GSK Investigational Site
Miami Florida 33136
Updated

Patients are needed to participate in a clinical research study of Gynaecological follow-up to evaluate Human Papillomavirus (HPV) Type 16/18 Infections or Cervical Neoplasia

Memorial Health University Medical Center
Savannah Georgia 31403

A clinical trial to evaluate treatments using live-attenuated Listeria monocytogenes cancer vaccine ADXS11-001 and laboratory biomarker analysis for patients with Cervical Cancer

GSK Investigational Site
Honolulu Hawaii 96826
Updated

Patients are needed to participate in a clinical research study of Gynaecological follow-up to evaluate Human Papillomavirus (HPV) Type 16/18 Infections or Cervical Neoplasia

GSK Investigational Site
Iowa City Iowa 52242
Updated

Patients are needed to participate in a clinical research study of Gynaecological follow-up to evaluate Human Papillomavirus (HPV) Type 16/18 Infections or Cervical Neoplasia

GSK Investigational Site
Iowa City Iowa 52242

Patients are needed to participate in a clinical research study of Gynaecological follow-up, Cervarix™ and Placebo control to evaluate Human Papillomavirus Infection or Cervical Neoplasia

GSK Investigational Site
Wichita Kansas 67207

Patients are needed to participate in a clinical research study of Gynaecological follow-up, Cervarix™ and Placebo control to evaluate Human Papillomavirus Infection or Cervical Neoplasia

Johns Hopkins University
Baltimore Maryland 21287-8936

A clinical trial to evaluate treatments using live-attenuated Listeria monocytogenes cancer vaccine ADXS11-001 and laboratory biomarker analysis for patients with Cervical Cancer

Washington University School of Medicine
St. Louis Missouri 63110

A clinical trial to evaluate treatments using live-attenuated Listeria monocytogenes cancer vaccine ADXS11-001 and laboratory biomarker analysis for patients with Cervical Cancer

GSK Investigational Site
Albuquerque New Mexico 87131
Updated

Patients are needed to participate in a clinical research study of Gynaecological follow-up to evaluate Human Papillomavirus (HPV) Type 16/18 Infections or Cervical Neoplasia

Montefiore Medical Center-Weiler Division
Bronx New York 10461

A clinical trial to evaluate treatments using live-attenuated Listeria monocytogenes cancer vaccine ADXS11-001 and laboratory biomarker analysis for patients with Cervical Cancer

Memorial Sloan-Kettering Cancer Center
New York New York 10022

A clinical trial seeking patients for a research study of compound 31543 Calcitriol

Carolinas Medical Center
Charlotte North Carolina 28203

A clinical trial to evaluate treatments using live-attenuated Listeria monocytogenes cancer vaccine ADXS11-001 and laboratory biomarker analysis for patients with Cervical Cancer

Athens Ohio 45701

Patients are needed to participate in a clinical research study to evaluate Uterine Cervical Cancer

Case Western Reserve University
Cleveland Ohio 44106

A clinical trial to evaluate treatments using live-attenuated Listeria monocytogenes cancer vaccine ADXS11-001 and laboratory biomarker analysis for patients with Cervical Cancer

Gallipolis Ohio 45631

Patients are needed to participate in a clinical research study to evaluate Uterine Cervical Cancer

Logan Ohio 43138

Patients are needed to participate in a clinical research study to evaluate Uterine Cervical Cancer

Lake University Ireland Cancer Center
Mentor Ohio 44060

A clinical trial to evaluate treatments using live-attenuated Listeria monocytogenes cancer vaccine ADXS11-001 and laboratory biomarker analysis for patients with Cervical Cancer

University of Oklahoma Health Sciences Center
Oklahoma City Oklahoma 73104

A clinical trial to evaluate treatments using live-attenuated Listeria monocytogenes cancer vaccine ADXS11-001 and laboratory biomarker analysis for patients with Cervical Cancer

UT MD Anderson Cancer Center
Houston Texas 77030

Patients are needed to participate in a clinical research study evaluating Interview and Questionnaire

GSK Investigational Site
Wenatchee Washington 98801

Patients are needed to participate in a clinical research study of Gynaecological follow-up, Cervarix™ and Placebo control to evaluate Human Papillomavirus Infection or Cervical Neoplasia

GSK Investigational Site
Perth Western Australia
Updated

Patients are needed to participate in a clinical research study of Gynaecological follow-up to evaluate Human Papillomavirus (HPV) Type 16/18 Infections or Cervical Neoplasia

GSK Investigational Site
Campinas 13083-970

Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females

GSK Investigational Site
Campinas 13083-970
Updated

Patients are needed to participate in a clinical research study of Gynaecological follow-up to evaluate Human Papillomavirus (HPV) Type 16/18 Infections or Cervical Neoplasia

GSK Investigational Site
Curitiba 80060-150
Updated

Patients are needed to participate in a clinical research study of Gynaecological follow-up to evaluate Human Papillomavirus (HPV) Type 16/18 Infections or Cervical Neoplasia

GSK Investigational Site
Porto Alegre Rio Grande Do Sul 90035-003

Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females

GSK Investigational Site
Porto Alegre Rio Grande Do Sul 90035-003
Updated

Patients are needed to participate in a clinical research study of Gynaecological follow-up to evaluate Human Papillomavirus (HPV) Type 16/18 Infections or Cervical Neoplasia

GSK Investigational Site
Edmonton Alberta T6G 2C8

Patients are needed to participate in a clinical research study of Gynaecological follow-up, Cervarix™ and Placebo control to evaluate Human Papillomavirus Infection or Cervical Neoplasia

GSK Investigational Site
Halifax Nova Scotia B3K 6R8

Patients are needed to participate in a clinical research study of Gynaecological follow-up, Cervarix™ and Placebo control to evaluate Human Papillomavirus Infection or Cervical Neoplasia

GSK Investigational Site
Sherbrooke Quebec J1H 1Z1

Patients are needed to participate in a clinical research study of Gynaecological follow-up, Cervarix™ and Placebo control to evaluate Human Papillomavirus Infection or Cervical Neoplasia

GSK Investigational Site
Truro Nova Scotia B2N 1L2

Patients are needed to participate in a clinical research study of Gynaecological follow-up, Cervarix™ and Placebo control to evaluate Human Papillomavirus Infection or Cervical Neoplasia

GSK Investigational Site
Vancouver British Columbia V6H 3N1

Patients are needed to participate in a clinical research study of Gynaecological follow-up, Cervarix™ and Placebo control to evaluate Human Papillomavirus Infection or Cervical Neoplasia

Cancer Institute ＆ Hospital Chinese Academy of Medical Sciences
Beijing 100021

A clinical trial seeking patients for a research study of HPV Vaccine and HEV vaccine

Jiangsu Provincial Centre for Disease Control and Prevention
Nanjing Jiangsu 210009

Patients are needed to participate in a clinical research study evaluating Human papillomavirus type 16/18 Bivalent Vaccine and HBV vaccine for the treatment of Cervical Intraepithelial Neoplasia or Cervical Cancer

University Hospital for Infectious Diseases, Croatia
Zagreb 10 000

A clinical trial seeking patients for a research study for the treatment of Cervical Cancer

Hvidovre Hospital
Hvidovre

A clinical research study of BD HPV assay on Viper LT for the treatment of Uterine Cervical Neoplasms

GSK Investigational Site
Aanekoski 44100

A Phase 4 clinical study for patients with Human Papillomavirus (HPV) Infection

GSK Investigational Site
Hameenlinna 13100

A Phase 4 clinical study for patients with Human Papillomavirus (HPV) Infection

GSK Investigational Site
Helsinki 00100

A Phase 4 clinical study for patients with Human Papillomavirus (HPV) Infection

GSK Investigational Site
Helsinki 00610
Updated

Patients are needed to participate in a clinical research study of Gynaecological follow-up to evaluate Human Papillomavirus (HPV) Type 16/18 Infections or Cervical Neoplasia

GSK Investigational Site
Hyvinkaa 05800

A Phase 4 clinical study for patients with Human Papillomavirus (HPV) Infection